This Week in Cell

An international team led by investigators in Germany and the US describe the transcription factor binding-based scheme they established for evaluating loci linked to type 2 diabetes risk. In their Cell study, the researchers demonstrated that this integrative computational strategy — which takes into account transcription factor binding site phylogeny and conservation in multiple species — can track down type 2 diabetes-associated variants with mechanistic ties to the disease.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.